Company Filing History:
Years Active: 2023
Title: Albino Bonazzi: Innovator in Pharmaceutical Combinations
Introduction
Albino Bonazzi is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of tumors. His innovative work has led to the development of a unique pharmaceutical combination that has the potential to enhance cancer treatment.
Latest Patents
Bonazzi holds a patent for a pharmaceutical combination of an EP4 antagonist and immune checkpoint inhibitors for the treatment of tumors. This invention provides a pharmaceutical combination comprising the EP4 antagonist of Formula (R)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)cyclopropyl)-benzoic acid or a pharmaceutically acceptable salt thereof, along with at least one immune checkpoint inhibitor. Additionally, a polymorphic form A of sodium salt of the EP4 antagonist is characterized by a specific powder XRD spectrum, which is also described for use in tumor treatment.
Career Highlights
Bonazzi is associated with Rottapharm Biotech S.r.l., where he continues to advance his research and development efforts. His work is pivotal in the pharmaceutical industry, particularly in oncology.
Collaborations
He has collaborated with notable colleagues such as Lucio C Rovati and Antonio Giordani, contributing to the advancement of innovative pharmaceutical solutions.
Conclusion
Albino Bonazzi's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight his role as a significant inventor in the field. His patent for a pharmaceutical combination demonstrates the potential for improved therapeutic strategies against tumors.